KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other financing activities (2016 - 2025)

Historic Other financing activities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$33.0 million.

  • Novartis Ag's Other financing activities fell 21785.71% to -$33.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$203.0 million, marking a year-over-year decrease of 33604.65%. This contributed to the annual value of -$203.0 million for FY2025, which is 33604.65% down from last year.
  • Latest data reveals that Novartis Ag reported Other financing activities of -$33.0 million as of Q4 2025, which was down 21785.71% from $22.0 million recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Other financing activities peaked at $150.0 million during Q4 2023, and registered a low of -$215.0 million during Q2 2025.
  • Moreover, its 5-year median value for Other financing activities was $22.0 million (2022), whereas its average is $7.4 million.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 278333.33% in 2022, then skyrocketed by 30909.09% in 2025.
  • Novartis Ag's Other financing activities (Quarter) stood at $6.0 million in 2021, then plummeted by 2783.33% to -$161.0 million in 2022, then skyrocketed by 193.17% to $150.0 million in 2023, then plummeted by 81.33% to $28.0 million in 2024, then plummeted by 217.86% to -$33.0 million in 2025.
  • Its Other financing activities was -$33.0 million in Q4 2025, compared to $22.0 million in Q3 2025 and -$215.0 million in Q2 2025.